Protocol Design White Papers & Case Studies

1. Human Abuse Potential 4/17/2024

   With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.

2. Patient Engagement: Early Cancer Detection Blood Draw 4/17/2024

   Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.

3. Cystic Fibrosis: Global Clinical Trial Landscape (2024) 4/8/2024

   Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.

4. Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024) 4/8/2024

   Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.

5. Patient Caregiver Network Improves Post-Seizure Trial Data 3/26/2024

   Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.

6. Study Start-Up Challenges: Hard Realities, Effective Strategies 3/13/2024

   Launching a study is complex, and the time between protocol approval and the first patient visit has increased dramatically. How can companies reverse this trend and accelerate study start-ups?

7. Precision Oncology Clinical Trials And Statistics 2024 3/12/2024

   Delve into the latest advancements in clinical trials, targeted therapies, and the promising horizon of cancer care.

8. Quality By Design: Better Data Using Participant Insights 3/12/2024

   While clinical trials will always encounter challenges in driving quality experiences and data, there exists one approach that’s backed by regulatory agencies and proven to lead to better outcomes.

9. Streamlining Study Start-Up For Accelerated Drug Development 2/20/2024

   Discover how we accelerated a Phase 1 study’s start-up time by 70%! This case study shares insights on streamlining communication, strategic planning, and more.

10. Trial Rescue: Leadership Approach To Propel Clinical Development 2/16/2024

    Learn how Halloran's assistance was able to improve a rare disease biotechnology company’s development and operations, communication workflow, and avoid the delay of a gene therapy trial.